| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 1 Sep 2025 | 28 Aug 2025 |
| Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/09/2025 inter alia to consider and approve 1)The Directors Report and Secretarial Audit Report alongwith annexure for the Financial Year 2024-25. 2)To Convene the 43rd Annual General Meeting (AGM) of the Members of the Company and approve the draft notice of 43rd Annual General Meeting (AGM) of the Company. 3)To fix the cut-off date for e-voting for the 43rdAnnual General Meeting of the Company. 4)To appoint Mr. Chintan K. Patel Practicing Company Secretary (Mem No: A31987 COP: 11959) as a Scrutinizer to ascertain voting process of 43rd Annual General Meeting (AGM).5)To appoint Mr. Chintan K. Patel Practicing Company Secretary (Mem No: A31987 COP: 11959) Ahmedabad as the Secretarial Auditors of the Company for the period of five consecutive financial years i.e. from F.Y. 2025-26 to 2029-30 and 6)To consider any other matter with the permission of the Chair. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e., Monday, 1st September, 2025 has discussed agendas as described in Outcome. (As per BSE Announcement Dated on 01/09/2025) | ||
| Board Meeting | 30 Aug 2025 | 30 Aug 2025 |
| Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (Listing Regulations), we wish to inform you that based on the recommendation of the Nomination & Remuneration Committee, the Board at its meeting held today i.e. August 30, 2025 has approved the appointment of Mr. Sarang Bharatbhai Pathak (DIN: 02663344) as Additional Director (Non-Executive - Non Independent) of the Company subject to the approval of the shareholders of the Company in the General Meeting. | ||
| Board Meeting | 13 Aug 2025 | 8 Aug 2025 |
| Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 inter alia to consider and approve the Un-audited Standalone and Consolidated Financial results along with the Limited Review Report of the Company for the Quarter ended 30th June 2025 and any other business with the permission of the Chair. The Board of Directors of the Company at its meeting held today i.e. Wednesday , August 13, 2025 at Registered Office of the Company has inter alia considered and approved the Un-audited Standalone and Consolidated Financial Results along with Limited Review Report of the Company for the Quarter ended on 30th June, 2025. (As Per BSE Announcement Dated on: 13.08.2025) | ||
| Board Meeting | 12 May 2025 | 6 May 2025 |
| Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 inter alia to consider and approve The Audited Standalone and Consolidated Financial statements and Financial results of the Company for the quarter and year ended March 31 2025 and 2. Any other business with the permission of Chair. Audited Standalone and Consolidated Financial Results along with Audit Report of the Company for the Quarter and Financial Year ended 31st March, 2025. The Board of Directors of the Company at its meeting held today i.e. Monday, 12th May, 2025 at Registered Office of the Company has inter alia considered and approved the following businesses: 1.Audited Standalone and Consolidated Financial Results along with Audit Report of the Company for the Quarter and Financial Year ended 31stMarch, 2025 . 2. Appointment of M/s. Rahul Doshi & Co., Chartered Accountants (FRN: 150982W, Membership No. 117160) as Internal Auditor of the Company for the Financial year 2025-26. 3. Appointment of Mr. Chintan K. Patel, Practicing Company Secretary (Membership No. A31987, COP: 11959) as Secretarial Auditor of the Company for the Financial year 2024-25.4. Appointment of Mr. Hitesh Pradeep Rijwani (DIN: 11030634) as an Additional Director (Non- Executive, Independent Director) and 5. Reconstitution of Committees of the Board w.e.f. 12thMay, 2025. (As Per BSE Announcement Dated on: 12/05/2025) Revised Outcome of the Board Meeting pertaining to clarification on Typographical Error in the Notes related to Financial Results submission for the quarter and year ended March 31, 2025 (As Per BSE Announcement Dated on 13.05.2025) | ||
| Board Meeting | 20 Mar 2025 | 20 Mar 2025 |
| Appointment of Ms. Siddhi Shah as Company Secretary w.e.f. 20.03.2025 | ||
| Board Meeting | 31 Jan 2025 | 24 Jan 2025 |
| Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2025 inter alia to consider and approve 1. Unaudited Standalone and Consolidated Results along with Limited Review Report for the Quarter and Nine Months ended 31st December 2024; 2. Any other business with the permission of Chairman. Outcome of the Board Meeting held on 31st January, 2025 at 04:00 P.M. inter alia considered and approved Un-audited Financial Results for the Quarter and Nine Months Ended 31st December, 2024. (As Per BSE Announcement Dated on: 31/01/2025) | ||
| Board Meeting | 17 Oct 2024 | 10 Oct 2024 |
| Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/10/2024 inter alia to consider and approve Notice is hereby given that meeting of Board of Directors scheduled to be held on Thursday 17th October 2024 at 5:00 PM at Registered Office of the Company. Pursuant to provisions of Regulation 33 of SEBI (LODR) Regulations, 2015, Board of DIrectors has approved Unaudited Financial Results for the Quarter and Half Year Ended 30th September, 2024. (As Per BSE Announcement dated on 17.10.2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.